APUSNYSEPharmaceutical PreparationsFiscal year ends December 31
Apimeds Pharmaceuticals US, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$3.50−0.54 (-13.37%)
Close on Oct 19, 2026
- Market cap
- $6.00M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Apimeds Pharmaceuticals US's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Apimeds Inc. | 4,316,618 | 34.30% | 13D (active) amendment | May 7, 2026 |
| Waqas Khatri | 1,397,021 | 9.99% | 13G (passive) | Dec 31, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Erik C. Emerson | Chief Executive Officer, Director | 750,000 | 49.70% | Oct 17, 2025 |
| Christopher Kim | Chairman and CMO, Director | 277,500 | 18.39% | Oct 17, 2025 |
| Mark Corrao | Chief Financial Officer | – | – | May 8, 2025 |
| Bennett Weintraub | Director | – | – | Nov 13, 2025 |
| Hankil Yoon | Director | – | – | Nov 13, 2025 |
| Carol A. O'Donnell | Director | – | – | Nov 13, 2025 |
| Elona Kogan | Director | – | – | Nov 13, 2025 |
| Jakap Koo | Director | 643,885 | 42.67% | Nov 13, 2025 |
| Inc. Inscobee | 10% owner | 5,801,234 | 384.41% | Nov 21, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Christopher Kim Chairman and CMO, Director | May 16, 2025 | Award | +250,000 | – | – | 277,500 |
| Erik C. Emerson Chief Executive Officer, Director | May 16, 2025 | Award | +750,000 | – | – | 750,000 |
| Christopher Kim Chairman and CMO, Director | May 14, 2025 | Buy | +7,730 | $1.86 | $14.38K | 27,500 |
| Christopher Kim Chairman and CMO, Director | May 13, 2025 | Buy | +19,770 | $1.82 | $35.98K | 19,770 |
| Inc. Inscobee 10% owner | May 12, 2025 | Conversion | +71,090 | $2.60 | $184.83K | 2,055,706 |
| Inc. Inscobee 10% owner | May 12, 2025 | Conversion | +44,041 | $2.60 | $114.51K | 2,099,747 |
| Jakap Koo Director | May 12, 2025 | Buy | +28,500 | $1.99 | $56.72K | 643,885 |
| Inc. Inscobee 10% owner | May 12, 2025 | Buy | +500,000 | $4.00 | $2.00M | 1,984,616 |
| Inc. Inscobee 10% owner | May 12, 2025 | Conversion | +182,002 | $2.60 | $473.21K | 4,316,618 |
| Inc. Inscobee 10% owner | May 12, 2025 | Conversion | +71,090 | $2.60 | $184.83K | 4,387,708 |
| Inc. Inscobee 10% owner | May 12, 2025 | Conversion | +44,041 | $2.60 | $114.51K | 2,028,657 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.